Ed Hrubiec

Ed Hrubiec is an accomplished professional in the pharmaceutical industry, currently serving as the Senior Field Access Director for Ipsen, overseeing the Northeast, Mid-Atlantic, and Mid-West regions focusing on rare diseases since May 2025. Previously, Ed held the position of Regional Business Director at ITF Therapeutics LLC, where responsibilities included managing the Northeast region for Duchenne Muscular Dystrophy (DMD) within the rare disease sector. Ed's extensive experience also includes roles such as Regional Access Manager and Regional Business Director for Amylyx Pharmaceuticals, Area Access Director for Intercept Pharmaceuticals, and various sales and access positions at AbbVie, Vertex Pharmaceuticals, Gilead Sciences, and Abbott. Ed earned a Bachelor of Science in Applied Professional Sciences with a minor in Business Marketing from the University of South Carolina in 1998.